News from Atom Therapeutics

28 October, 2025
Atom Therapeutics Announces Partnering Opportunities For New Gout Therapies at BIO-Europe 2025 in Vienna
PRESS RELEASE Atom Therapeutics Announces Partnering Opportunities For New Gout Therapies at BIO-Europe...
21 October, 2025
Atom Therapeutics to Present Positive Data from Clinical Trials of Its Lead Novel Oral Drugs for Chronic Gout and Acute Gout Flares at ACR Convergence 2025
PRESS RELEASE Atom Therapeutics to Present Positive Data from Clinical Trials of Its Lead Novel Oral...
15 September, 2025
Atom Therapeutics Enrolls First Patient in Multicenter Global Phase 2 Trial of ABP-745 for Acute Gout Flares Share
  PRESS RELEASE Atom Therapeutics Enrolls First Patient in Multicenter Global Phase 2 Trial of...
07 September, 2025
Atom Therapeutics Announces Positive Topline Results of Lingdolinurad (ABP-671) in Phase 2b/3 Trial for Chronic Gout
PRESS RELEASE Atom Therapeutics Announces Positive Topline Results of Lingdolinurad (ABP-671) in Phase...
01 July, 2025
Atom Therapeutics Names Fang Min Clinical Vice President in China
  PRESS RELEASE Atom Therapeutics Names Dr. Min Fang as Clinical Vice President in China ZHEJIANG, China...
22 May, 2025
Atom Therapeutics Joins Gout Education Society on Gout Awareness Day, May 22, to Help Educate the Public on Risk Factors and Treatment Options for This Growing Disease
PRESS RELEASE Atom Therapeutics Joins Gout Education Society on Gout Awareness Day, May 22, to Help Educate...
03 December, 2024
Atom Therapeutics and China Medical System Holdings Enter Exclusive Commercialization Agreement for Lingdolinurad (ABP-671) to Treat Chronic Gout and Hyperuricemia
PRESS RELEASE Atom Therapeutics and China Medical System Holdings Enter Exclusive Commercialization Agreement...
12 November, 2024
Atom Therapeutics to Present Positive Data from a Phase 1 Trial of Its Novel URAT1 Inhibitor for Chronic Gout (ABP-671) in Participants with Chronic Kidney Disease at ACR Convergence 2024
PRESS RELEASE Atom Therapeutics to Present Positive Data from a Phase 1 Trial of Its Novel URAT1 Inhibitor...
12 November, 2024
Atom Bioscience Changes Name to Atom Therapeutics To Better Reflect Focus on Development of Best-in-Class Novel Oral Drugs for Inflammatory and Metabolic Diseases
PRESS RELEASE Atom Bioscience Changes Name to Atom Therapeutics To Better Reflect Focus on Development...
21 May, 2024
Atom Bioscience Marks Gout Awareness Day with Video Detailing Risks of Hyperuricemia, the Cause of Gout
PRESS RELEASE Atom Bioscience Marks Gout Awareness Day with Video Detailing Risks of Hyperuricemia, the...

Atom Therapeutics in the News

Fierce Biotech: Atom claims phase 3 win shows gout drug can beat competition in efficacy, safety
Pipeline Review: Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745 for Acute Gout
Endpoints: Atom Bioscience raises $83M in Series D for URAT1 inhibitor in chronic gout treatment
BioSpace: Atom Bioscience Doses First Patient in Phase 2b/3 Clinical Trial of a New Treatment for Chronic Gout
Fierce Biotech: Atom Bioscience Hopes to Make Big Bang with New Gout Awareness Campaign
Practical Pain Management: Gout Myths -- Busted
BioWorld: Atom Bioscience Planning Phase III Gout Trial After Encouraging Mid-Stage Readout
BioSpace: Atom Bioscience Announces Positive Phase 2a Results For Investigational New Drug to Treat Chronic Gout

Industry News

HCPLive.com: Real-World Study Reveals Poor Disease Control in Adults with Gout
HCPLive.com: Study Explores the Patient Perspective of Gout Remission
HCPLive.com: Patients with Gout More Likely to Experience Stroke, Heart Failure
Docwirenews: Serum Uric Acid Levels in Patients with Gout
AJMC: The Connection Between Gout and CVD Requires Cross-Specialty Collaboration
Docwirenews: Gout Associate with Increased CVD and Heart Failure Risk in Black Population
Renal & Urology News: Hyperuricemia, Gout Increase Heart Failure, Death Risk
Practical Pain Management: How can I get my patients to understand that gout is a chronic disease?
WebMD: The Link Between Gout and Depression - What to Know
Docwirenews: Study Reveals High CVD Risk in Gout Patients
Contemporary OBGYN: Exploring the gender differences of comorbidities in patients with gout
HCP Live: Mortality Risk in Gout Has Persisted for Decades Despite Advances in Care
News-Medical.net: Gout unveiled as surprising culprit in neurodegenerative diseases
Renal & Urology News: Gout Burden Increasing Among Asians in the United States
Healio: Well-controlled serum urate levels in gout result in lower fracture risk
Clinical Trials Arena: Atom Bioscience reports positive Phase IIa chronic gout therapy trial data
Rheumatology Advisor: National Kidney Month Spotlight: Uric Acid and Its Role in Chronic Kidney Disease
HCPLive: Gout Isn’t a Punchline. It’s Time to Stop Treating it Like One
Physicians Weekly: ULT for Gout Leads to Long-Term Reduction in Hospitalization Risk
The Irish News: Why a gout pill could cut high blood pressure - and boost your sex life
Kidney Disease Among Top Contributors to Excess Death Risk in Veterans With Gout
Renal & Urology News: Kidney Disease Among Top Contributors to Excess Death Risk in Veterans With Gout
News-Medical.net: Gout: Disease of Kings now a 21st Century Epidemic
News-Medical.net: Study finds a novel therapeutic target for prevention and treatment of gout
DocWireNews: Depression and Anxiety in Patients After Gout Diagnosis
Arthritis & Rheumatology: Study Compares Gout Treatments with Different Mechanisms of Action - URAT1 Inhibitor vs Xanthine Oxidase Inhibitor
Pharmacy Times: Study: Gout Flare Ups Can Lead to Four-Times Higher Risk of Heart Attack, Stroke
New Life Outlook: Gout and Eye Problems
Health Central: Gout Myths—Busted
Healthline: How Gout Flare-ups May Increase the Risk of Heart Attack, Stroke
Physicians Weekly: Urate-Lowering Treatments Compared for Gout
Arthritis & Rheumatology: Superiority of Low-Dose Benzbromarone to Low-Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion
Healio.com: 'Horribly mismanaged': Debate over gout treatment rages as cases surge
Gout and Heart Disease: Why You're at Increased Risk
Physicians Weekly: Analyzing the Genetics of Hyperuricemia & Gout in Post-Partum Racial/Ethnic Groups